234 related articles for article (PubMed ID: 27338113)
1. How we provide blood transfusion support in two large US liver transplant programs.
Zubair AC; Torp K; Eichbaum Q
Transfusion; 2016 Aug; 56(8):1938-43. PubMed ID: 27338113
[No Abstract] [Full Text] [Related]
2. Transfusion services operations during the COVID-19 pandemic: Results from AABB survey.
Pagano MB; Rajbhandary S; Nunes E; Cohn CS
Transfusion; 2020 Nov; 60(11):2760-2762. PubMed ID: 33217023
[No Abstract] [Full Text] [Related]
3. Practical approaches to limited resources.
Lin CK
Vox Sang; 2004 Jul; 87 Suppl 2():172-5. PubMed ID: 15209910
[No Abstract] [Full Text] [Related]
4. Blood program in Japan: current status.
Ikeda H
Transfus Apher Sci; 2002 Apr; 26(2):129-33. PubMed ID: 12121069
[No Abstract] [Full Text] [Related]
5. Safe blood transfusion practices in blood banks of Karachi, Pakistan.
Kassi M; Afghan AK; Khanani MR; Khan IA; Ali SH
Transfus Med; 2011 Feb; 21(1):57-62. PubMed ID: 21029219
[TBL] [Abstract][Full Text] [Related]
6. Texas blood.
Busby J
Tex Med; 1991 Oct; 87(10):40-7. PubMed ID: 1962295
[No Abstract] [Full Text] [Related]
7. The U.S. blood supply.
Epstein JS
Am Fam Physician; 2000 Jan; 61(2):549-50. PubMed ID: 10670510
[No Abstract] [Full Text] [Related]
8. Safer haemotherapy: the responsibilities of government, transfusion service, blood donors, and physician-users.
Moore BP
Haematologia (Budap); 1995; 27(1):39-45. PubMed ID: 12051295
[TBL] [Abstract][Full Text] [Related]
9. [The experience of a blood-bank doctor in Chile].
Martinez C
Transfus Clin Biol; 2006 Sep; 13(3):203-5. PubMed ID: 17010653
[TBL] [Abstract][Full Text] [Related]
10. The Spanish program for rare blood donors.
Muñiz-Diaz E; Castro A; Flores E; Larrea L; Puente F; Ayape M; Pérez-Vaquero MA
Immunohematology; 2016 Jun; 32(2):59-61. PubMed ID: 27901570
[No Abstract] [Full Text] [Related]
11. Blood groups differ on donor deferral.
Mitka M
JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807
[No Abstract] [Full Text] [Related]
12. ISBT Board response to the Dublin consensus statement.
Flanagan P
Vox Sang; 2011 Feb; 100(2):250-1. PubMed ID: 20946536
[No Abstract] [Full Text] [Related]
13. [Blood transfusion and supply chain management safety].
Quaranta JF; Caldani C; Cabaud JJ; Chavarin P; Rochette-Eribon S
Presse Med; 2015 Feb; 44(2):214-20. PubMed ID: 25578550
[TBL] [Abstract][Full Text] [Related]
14. Blood supply safety: an NHLBI perspective.
Glynn SA
Transfusion; 2008 Aug; 48(8):1541-4. PubMed ID: 18713102
[No Abstract] [Full Text] [Related]
15. Blood counts.
Shamash J
Nurs Times; 2002 Nov 5-11; 98(45):22-6. PubMed ID: 12479141
[No Abstract] [Full Text] [Related]
16. Planning for future demand.
Gogarty G; Wickenden C
Vox Sang; 2004 Jul; 87 Suppl 2():149-50. PubMed ID: 15209902
[No Abstract] [Full Text] [Related]
17. Contemplating the effect on blood availability if the interdonation interval of 56 days is prolonged.
Sayers M; Centilli J
Transfusion; 2013 May; 53(5):1132-6. PubMed ID: 22998106
[No Abstract] [Full Text] [Related]
18. Oversight and monitoring of blood safety in the United States.
Busch M; Chamberland M; Epstein J; Kleinman S; Khabbaz R; Nemo G
Vox Sang; 1999; 77(2):67-76. PubMed ID: 10516550
[TBL] [Abstract][Full Text] [Related]
19. Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009.
Spinella PC; Dressler A; Tucci M; Carroll CL; Rosen RS; Hume H; Sloan SR; Lacroix J;
Transfusion; 2010 Nov; 50(11):2328-35. PubMed ID: 20529008
[TBL] [Abstract][Full Text] [Related]
20. The Rapa Nui caveat.
Sayers M
Transfusion; 2009 Feb; 49(2):385-7. PubMed ID: 19389216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
